Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 /CenExel, a leading network of clinical research sites, proudly ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

“A new non-opioid analgesic therapeutic class ... they can cause problems with addiction.” “These pain medications, suzetrigine, Journavx as it’s called, works sort of more at the location ...

Acute pain affects over 80 million Americans each year, with nearly half prescribed opioids. With JOURNAVX's approval, physicians now have a new, non-opioid treatment option that delivers ...

SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 / CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals ...